The company’s product offerings will include raw flower, pre-rolls, extracted distillate and vaporizable oil, as well as Ilera Healthcare branded tinctures, topicals and medically-blended vapes.
In December 2018, TerrAscend was awarded the right to apply for one of six vertically integrated permits, out of 146 applications, in the state of New Jersey. TerrAscend was the second entity to receive its cultivation permit in January 2020, among the six winning applicants. At that time, initial cultivation began in a temporary on-site area while construction of TerrAscend’s greenhouse was completed. With this new permit, plants previously grown in the temporary area will be transferred to the greenhouse.
After securing additional processing and dispensing approvals, the full permit will allow TerrAscend to operate a production facility and up to three Alternative Treatment Centers (“ATCs”), or dispensaries, in the North region of New Jersey. The first Apothecarium-branded ATC is expected to open in Phillipsburg in Q4 2020, followed by two additional ATCs upon regulatory approval.